- Home
- LPCN vs GRFX Comparison
LPCN vs GRFX Comparison
Compare LPCN & GRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- GRFX
- Stock Information
- Founded
- LPCN 1997
- GRFX 1981
- Country
- LPCN United States
- GRFX Hong Kong
- Employees
- LPCN N/A
- GRFX N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- GRFX
- Sector
- LPCN Health Care
- GRFX
- Exchange
- LPCN Nasdaq
- GRFX Nasdaq
- Market Cap
- LPCN 16.4M
- GRFX 18.1M
- IPO Year
- LPCN N/A
- GRFX N/A
- Fundamental
- Price
- LPCN $3.24
- GRFX $1.00
- Analyst Decision
- LPCN Strong Buy
- GRFX Hold
- Analyst Count
- LPCN 1
- GRFX 1
- Target Price
- LPCN $10.00
- GRFX N/A
- AVG Volume (30 Days)
- LPCN 10.5K
- GRFX 36.5K
- Earning Date
- LPCN 03-13-2025
- GRFX 01-01-0001
- Dividend Yield
- LPCN N/A
- GRFX N/A
- EPS Growth
- LPCN N/A
- GRFX N/A
- EPS
- LPCN N/A
- GRFX N/A
- Revenue
- LPCN $11,198,144.00
- GRFX $24,184,100.00
- Revenue This Year
- LPCN N/A
- GRFX N/A
- Revenue Next Year
- LPCN $37.31
- GRFX N/A
- P/E Ratio
- LPCN N/A
- GRFX N/A
- Revenue Growth
- LPCN N/A
- GRFX N/A
- 52 Week Low
- LPCN $2.91
- GRFX $0.71
- 52 Week High
- LPCN $11.79
- GRFX $2.75
- Technical
- Relative Strength Index (RSI)
- LPCN 41.52
- GRFX 42.11
- Support Level
- LPCN $3.00
- GRFX $0.84
- Resistance Level
- LPCN $3.57
- GRFX $1.29
- Average True Range (ATR)
- LPCN 0.24
- GRFX 0.25
- MACD
- LPCN -0.00
- GRFX -0.02
- Stochastic Oscillator
- LPCN 23.29
- GRFX 20.34
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.
About GRFX Graphex Group Limited each representing 20
Graphex Group Ltd is engaged in the sale of graphene products. It operates in three segments namely, the Graphene Products Segment includes Processing and sale of graphite and graphene-related products; the Landscape Architecture Design Segment includes Providing landscape architecture design; and the catering business focuses on the operation of restaurants. The company derives the majority of its revenue from the sale of graphene products segment.